<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Geleta D</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Klebsiella bacterial strains harboring Extended-Spectrum Beta-Lactamase (ESBL) enzymes are the primary culprits behind neonatal sepsis globally. These strains significantly impact clinical outcomes due to their multi-drug resistance patterns in local healthcare settings. In response to this spiraling threat, we studied the prevalence and clinical implications of ESBL-encoding genes in neonates hospitalized with confirmed sepsis.&lt;h4>Methods&lt;/h4>A correlational study was conducted on 51 neonates diagnosed with sepsis caused by ESBL-positive Klebsiella pneumoniae at Jimma Medical Center spanning from May 2022 to July 2023. Antimicrobial resistance profiles of the bacterial isolates were determined using the Kirby-Bauer diffusion test, while multiplex polymerase chain reacti</pubmed_abstract><journal>BMC infectious diseases</journal><pagination>1442</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11653740</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular and clinical insights into extended-spectrum β-lactamase genes of Klebsiella pneumoniae isolated from neonatal sepsis in Ethiopia.</pubmed_title><pmcid>PMC11653740</pmcid><pubmed_authors>Mihret A</pubmed_authors><pubmed_authors>Workneh N</pubmed_authors><pubmed_authors>Geleta D</pubmed_authors><pubmed_authors>Abebe G</pubmed_authors><pubmed_authors>Abdissa A</pubmed_authors><pubmed_authors>Cataldo RJ</pubmed_authors><pubmed_authors>Negash AA</pubmed_authors><pubmed_authors>Tilahun T</pubmed_authors><pubmed_authors>Beyene G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular and clinical insights into extended-spectrum β-lactamase genes of Klebsiella pneumoniae isolated from neonatal sepsis in Ethiopia.</name><description>&lt;h4>Background&lt;/h4>Klebsiella bacterial strains harboring Extended-Spectrum Beta-Lactamase (ESBL) enzymes are the primary culprits behind neonatal sepsis globally. These strains significantly impact clinical outcomes due to their multi-drug resistance patterns in local healthcare settings. In response to this spiraling threat, we studied the prevalence and clinical implications of ESBL-encoding genes in neonates hospitalized with confirmed sepsis.&lt;h4>Methods&lt;/h4>A correlational study was conducted on 51 neonates diagnosed with sepsis caused by ESBL-positive Klebsiella pneumoniae at Jimma Medical Center spanning from May 2022 to July 2023. Antimicrobial resistance profiles of the bacterial isolates were determined using the Kirby-Bauer diffusion test, while multiplex polymerase chain reacti</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-18T14:22:28.006Z</modification><creation>2025-04-04T21:45:28.691Z</creation></dates><accession>S-EPMC11653740</accession><cross_references><pubmed>39695444</pubmed><doi>10.1186/s12879-024-10344-w</doi></cross_references></HashMap>